Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.

Cardin R, Piciocchi M, Sinigaglia A, Lavezzo E, Bortolami M, Kotsafti A, Cillo U, Zanus G, Mescoli C, Rugge M, Farinati F.

BMC Cancer. 2012 May 15;12:177. doi: 10.1186/1471-2407-12-177. Erratum in: BMC Cancer. 2014;14:284. multiple author names corrected.

2.

Oxidative DNA damage in Barrett mucosa: correlation with telomeric dysfunction and p53 mutation.

Cardin R, Piciocchi M, Tieppo C, Maddalo G, Zaninotto G, Mescoli C, Rugge M, Farinati F.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S583-9. doi: 10.1245/s10434-013-3043-1. Epub 2013 Jun 7.

PMID:
23744553
3.

Cause-specific telomere factors deregulation in hepatocellular carcinoma.

El Idrissi M, Hervieu V, Merle P, Mortreux F, Wattel E.

J Exp Clin Cancer Res. 2013 Sep 11;32:64. doi: 10.1186/1756-9966-32-64.

4.

Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis.

Piciocchi M, Cardin R, Cillo U, Vitale A, Cappon A, Mescoli C, Guido M, Rugge M, Burra P, Floreani A, Farinati F.

Transl Res. 2016 Feb;168:122-133. doi: 10.1016/j.trsl.2015.08.012. Epub 2015 Sep 5.

PMID:
26408804
5.

Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.

Ueda T, Honda M, Horimoto K, Aburatani S, Saito S, Yamashita T, Sakai Y, Nakamura M, Takatori H, Sunagozaka H, Kaneko S.

Genomics. 2013 Apr;101(4):238-48. doi: 10.1016/j.ygeno.2013.02.007. Epub 2013 Feb 26. Erratum in: Genomics. 2013 Jun;101(6):376.

6.

Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC.

Salvi A, Abeni E, Portolani N, Barlati S, De Petro G.

Int J Oncol. 2013 Feb;42(2):391-402. doi: 10.3892/ijo.2012.1716. Epub 2012 Nov 28.

7.

Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.

Miura N, Horikawa I, Nishimoto A, Ohmura H, Ito H, Hirohashi S, Shay JW, Oshimura M.

Cancer Genet Cytogenet. 1997 Jan;93(1):56-62.

PMID:
9062581
8.

8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M.

J Gastroenterol Hepatol. 2008 Sep;23(9):1431-6. doi: 10.1111/j.1440-1746.2008.05502.x.

PMID:
18854000
9.

Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma.

Ichiba M, Maeta Y, Mukoyama T, Saeki T, Yasui S, Kanbe T, Okano J, Tanabe Y, Hirooka Y, Yamada S, Kurimasa A, Murawaki Y, Shiota G.

Liver Int. 2003 Oct;23(5):338-45.

PMID:
14708894
10.

[MicroRNA profiling in patients with hepatocellular carcinoma].

Wang CX, Song W, Li ZJ, Song B, Wu DH, Sun AM, Chen LH.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):976-7. Chinese.

11.

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N.

Gastroenterology. 2008 Jul;135(1):257-69. doi: 10.1053/j.gastro.2008.04.003. Epub 2008 Apr 11.

PMID:
18555017
12.

The correlation of hepatitis B virus pre-S mutation with cellular oxidative DNA damage in hepatocellular carcinoma.

Gwak GY, Lee DH, Moon TG, Choi MS, Lee JH, Koh KC, Paik SW, Park CK, Joh JW, Yoo BC.

Hepatogastroenterology. 2008 Nov-Dec;55(88):2028-32.

PMID:
19260471
13.

Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma.

Zeng W, van den Berg A, Huitema S, Gouw AS, Molema G, de Jong KP.

PLoS One. 2014 Apr 23;9(4):e95826. doi: 10.1371/journal.pone.0095826. eCollection 2014.

14.

microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.

Zhu XC, Dong QZ, Zhang XF, Deng B, Jia HL, Ye QH, Qin LX, Wu XZ.

Int J Mol Med. 2012 Dec;30(6):1321-6. doi: 10.3892/ijmm.2012.1140. Epub 2012 Sep 25.

PMID:
23023935
15.

The Relationship Between Single-Nucleotide Polymorphisms, the Expression of DNA Damage Response Genes, and Hepatocellular Carcinoma in a Polish Population.

Krupa R, Czarny P, Wigner P, Wozny J, Jablkowski M, Kordek R, Szemraj J, Sliwinski T.

DNA Cell Biol. 2017 Aug;36(8):693-708. doi: 10.1089/dna.2017.3664. Epub 2017 Jun 9.

PMID:
28598207
16.
17.

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, Wang Z, Ding G, Zhuang SM, Zheng L, Tao W, Cao X.

J Biol Chem. 2011 Oct 21;286(42):36677-85. doi: 10.1074/jbc.M111.270561. Epub 2011 Aug 30.

18.

Molecular analysis of PinX1 in human hepatocellular carcinoma.

Oh BK, Chae KJ, Park C, Park YN.

Oncol Rep. 2004 Oct;12(4):861-6.

PMID:
15375513
19.

Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.

Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.

J Gastroenterol Hepatol. 2011 Nov;26(11):1630-7. doi: 10.1111/j.1440-1746.2011.06758.x.

PMID:
21557766
20.

A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.

Akkız H, Bayram S, Bekar A, Akgöllü E, Ulger Y.

J Viral Hepat. 2011 Jul;18(7):e399-407. doi: 10.1111/j.1365-2893.2010.01414.x. Epub 2010 Dec 23.

PMID:
21692953

Supplemental Content

Support Center